Short Interest in Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) Declines By 35.4%

Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) was the target of a significant decrease in short interest during the month of August. As of August 14th, there was short interest totaling 11,255 shares, a decrease of 35.4% from the July 30th total of 17,416 shares. Approximately 1.2% of the company’s shares are short sold. Based on an average daily volume of 30,001 shares, the days-to-cover ratio is currently 0.4 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised Cuprina Holdings (Cayman) from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 26th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

Cuprina Holdings (Cayman) Stock Down 3.8%

Shares of NASDAQ:CUPR opened at $2.79 on Thursday. Cuprina Holdings has a 12 month low of $1.76 and a 12 month high of $19.60. The company’s fifty day simple moving average is $3.79 and its 200 day simple moving average is $3.23. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.35 and a current ratio of 2.35.

Cuprina Holdings (Cayman) Company Profile

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.